LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. The company is headquartered in Princeton, New Jersey and currently employs 163 full-time employees. The company went IPO on 2021-10-28. The firm is also pursuing the sale of its remaining pipeline assets.
8명의 애널리스트가 LIANY에 대해 제공한 주식 평가를 기반으로 Jun 01, 2024에 업데이트됨
Sell
Strong buy
0
Buy
0
Hold
3
Sell
2
Strong sell
3
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for LIANY. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: LIANY is a Sell candidate.
LIANY stock price ended at $0.09 on 금요일, after rising 0.00%
On the latest trading day Jan 16, 2026, the stock price of LIANY rose by 0.00%, climbing from $0.09 to $0.09. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.09 and a high of $0.09. Notably, trading volume dropped by 3.4K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 3.5K shares were traded, equating to a market value of approximately $9.7M.
LIANY 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 2
매도 신호 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
LIANY은 현재 2개의 매수 신호와 3개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 --입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
LIANY에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 LIANY 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.